GV20 Therapeutics
Business Services · 51-200 Employees
View Company Info for Free
Overview
Website
www.gv20tx.comRevenue
<$5 MillionIndustry
About GV20 Therapeutics
GV20 specializes in high throughput functional genomics and AI methodologies to identify new drug targets in cancer immunology. The company focuses on discovering and developing effective antibody drugs for cancer treatment. GV20 has established a robust portfolio of immuno-oncology antibody drug candidates. Their intended clients include pharmaceutical companies and research institutions involved in cancer therapeutics.Explore more
GV20 Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to GV20 Therapeutics
Compare insights from companies similar to GV20 Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$9.4M
51-200
Private
$343.7M
2020
Michael SecoraChief Financial Officer & Chief Corporate Development Officer
GV20 Therapeutics Tech Stack
A closer look at the technologies used by GV20 Therapeutics
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GV20 Therapeutics
Sign Up For FreeTo access detailed company insights
GV20 specializes in high throughput functional genomics and AI methodologies to identify new drug targets in cancer immunology. The company focuses on discovering and developing effective antibody drugs for cancer treatment. GV20 has established a robust portfolio of immuno-oncology antibody drug candidates. Their intended clients include pharmaceu... Read More
